beta blockers
-
Investors’ Back Radnor Firm’s Development of Blood Pressure Drug
Mineralys Therapeutics in Radnor is getting a $118 million investment from biotech investors in six nations to develop a new blood-pressure drug, writes Joseph N.…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
